NeutriSci International (NU) Stock Price, News & Analysis

Company Overview

NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: C$0.01 to C$0.01
• 50-Day Range: C$0.01 to C$0.01
• 52-Week Range: C$0.01 to C$0.02
• Volume: 105,000 shs
• Average Volume: 55,311 shs
• Market Capitalization: C$892.10 thousand
• P/E Ratio: N/A
• Dividend Yield: 2.61%
• Price Target: N/A
• Consensus Rating: N/A

NU Stock Analysis - Frequently Asked Questions

How have NU shares performed this year?

NeutriSci International's stock was trading at C$0.01 at the beginning of 2025. Since then, NU stock has increased by 0.0% and is now trading at C$0.01.

How do I buy shares of NeutriSci International?

Shares of NU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What other stocks do shareholders of NeutriSci International own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NeutriSci International investors own include Taiwan Semiconductor Manufacturing (TSM), Aurora Cannabis (ACB), Ford Motor (F), Akamai Technologies (AKAM), Pfizer (PFE), Viemed Healthcare (VMD) and Advanced Micro Devices (AMD).

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: CVE:NU
• CIK: N/A
• Web: www.neutrisci.com
• Phone: 403-264-6320
• Fax: N/A
• Employees: 147,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -175.93%

Debt

• Debt-to-Equity Ratio: 20.93
• Current Ratio: 0.02
• Quick Ratio: 0.02

Sales & Book Value

• Annual Sales: C$432.45 thousand
• Price / Sales: 2.06
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 25.00
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 178,420,000
• Free Float: N/A
• Market Cap: C$892.10 thousand
• Optionable: Not Optionable
• Beta: 0.82